Safety of Arthritis Drugs, Day 3. Part 4

This is the last day of a joint meeting of the FDA’s Arthritis and Drug Safety and Risk Management Advisory Committees. At the… read more

This is the last day of a joint meeting of the FDA’s Arthritis and Drug Safety and Risk Management Advisory Committees. At the end of the three-day forum the 32-member panel had recommended that arthritis drugs Celebrex and Bextra stay on the market with restrictions. This portion included the 17-15 vote that Vioxx should stay on the U.S. market, and other votes about restrictions on Vioxx. 

Dr. Wood is chairman of the Arthritis Advisory Committee, Drug Safety and Risk Management Committee. close

People in this video

  • Steven Abramson Chairman New York University Medical School->Rheumatology
  • Joan Bathon Professor Johns Hopkins University->Medical School
  • John Cush Chief Presbyterian Hospital (Dallas)->Rheumatology and Immunology
  • Ruth Day Senior Fellow Duke University->Aging Center
  • John Farrar Director University of Pennsylvania->Clinical Epidemiology and Biostatistics
  • Thomas Fleming Chairman University of Washington->Biostatistics
  • Curt Furberg Director Wake Forest University->Department of Public Health Services
  • Allan Gibofsky Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.
  • Peter Gross M.D. Chairman Hackensack University Medical Center->Internal Medicine
  • Charles Hennekens Professor University of Miami->School of Medicine
  • Eric Holmboe Vice President American Board of Internal Medicine->Evaluation Research
  • Norman Ilowite Chief Schneider Children's Hospital
  • John Jenkins Director U.S. Food and Drug Administration->Office of New Drugs
  • Leona Malone
  • Susan Manzi Professor University of Pittsburgh->School of Medicine
  • Louis Morris President Louis A. Morris and Associates
  • Steven E. Nissen M.D. Medical Director Cleveland Clinic Foundation->Cardiovascular Coord. Ctr.
  • Emil Paganini Head Cleveland Clinic Foundation->Dialysis Section
  • Richard Platt Professor Harvard University->Medical School
  • Robert Temple Director U.S. Food and Drug Administration->Office of Drug Evaluation
  • Alastair J. J. Wood M.D. Chairman U.S. Food and Drug Administration->Arthritis Advisory Cmte.
More People

Hosting Organization

More Videos From

Safety of Arthritis Drugs, Day 3,

More Videos
More information about

Safety of Arthritis Drugs, Day 3. Part 4

98 Views
Program ID:
185600-4
Category:
Public Affairs Event
Format:
Forum
Location:
Gaithersburg, Maryland, United States
First Aired:
Feb 19, 2005
Last Aired:
Feb 25, 2005

Airing Details

  • Feb 19, 2005 | 3:02pm EST | C-SPAN 1
  • Feb 25, 2005 | 1:52pm EST | C-SPAN 2